The MaRS Investment Accelerator Fund (IAF) is a Canadian seed fund operated by MaRS Discovery District with funding from the Government of Ontario.[1]
Portfolio
Companies in MaRS IAF's portfolio include:[2]
- Bright Angel Therapeutics
- DNAstack
- eMurmur
- Encycle Therapeutics
- Flosonics Medical
- Intellijoint Surgical
- Karos Health
- Medchart
- MedMe
- MindBridge Analytics
- Nudge Rewards
- Opencare
- Privacy Analytics
- Profound Medical
- Swift Medical
- TrendMD
- Welbi
- Zighra
External links
Treurnicht, I., & Nixon, G. (2014, December 9). 2012 MaRS Annual Report. Issuu; MaRS. https://issuu.com/derekaubichon/docs/mar-anr6786_2012_annual_report_elec/1 ↩︎
Portfolio. MaRS IAF. Retrieved July 6, 2023, from https://web.archive.org/web/20230706215815/https://www.marsiaf.com/portfolio ↩︎
